Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance

Share this content:
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance

Sponsors and Collaborators
Mario Negri Institute for Pharmacological Research

Contact
Piero Ruggenenti, MD
0039 035 269296
pruggenenti@ospedaliriuniti.bergamo.it

Principal Investigators
Giuseppe Remuzzi, MD, Department of Immunology and Clinical Transplantation / Mario Negri Institute for Pharmacological Research and Ospedali Riuniti BG
Norberto Perico, MD, Mario Negri Institute for Pharmacological Research, Ranica BG
Marina Noris, CH PhD, Mario Negri Institute for Pharmacological Research, Ranica BG
Martino Introna, MD, Cell and Gene therapy Laboratory "G. Lanzani" BG
Alessandro Rambaldi, MD, Hematology Unit - Ospedali Riuniti BG

ClinicalTrials.gov Identifier
NCT00752479

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters